An experimental cannabis drug for treating schizophrenia, developed by UK-based GW Pharmaceuticals Plc, was found to be superior to a placebo in a mid-stage trial. The company’s UK-listed shares jumped 12.5 percent, while U.S.-listed shares were up 10 pct. The drug, cannabidiol, was tested in 88 patients with schizophrenia, who had failed to respond to
Listen to Professor Markus Leweke Talk About His Research Using Cannabinoids To Treat Neuropsychiatric Disorders Cannabis Compounds Used to Treat Pain, Disease, and Psychiatric Disorders YouTube Description: Prof. Markus Leweke is a medical doctor at the Central Institute of Mental Health in Mannheim, Germany, he’s conducting research on pharmacological treatments for neuropsychiatric disorders, with a focus
Family History of Schizophrenia and Cannabis Use Good news for people who’ve worried that smoking too much marijuana (cannabis) — especially as a teenager — might lead to some dramatic problems in the future, even schizophrenia. Harvard: Marijuana Doesn’t Cause Schizophrenia New research from Harvard Medical School, in a comparison between families with a history
Schizophrenia is one of the most recognizable mental disorders in today’s society. While schizophrenia affects only 1% of the U.S. population, there seems to be a widespread fear among marijuana users of developing this condition. The root of this fear stems from the common yet controversial belief that using marijuana increases the risk of schizophrenia.
The effects of cannabis use on neurocognition in schizophrenia: A meta-analysis By Rabin RA, Zakzanis KK, and George TP | The Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada; Schizophrenia Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada Published in the National Institutes of Health’s U.S. National Library of Medicine Patients